Sexovid(F 6066)의 排卵 및 姙娠誘發效果에 關한 臨床的 檢討
Clinical Evaluation of the Ovulation and Pregnancy Inducing Action of Sexovid
申雄浩 ( ) - 신웅호 산부인과 의원
李相允 ( ) - 韓一病院 産婦人科
Abstract
The capacity of Sexovid(F6066) to induce ovulation and pregnancy in cases of anovulatory menses and aInenorrhea (1st and 2nd grade) was evaluated in 17 patients. Nine cases (52.9%) ovulated and five cases(29066) conceived; i.e., in 11 patients with anovulatory cycles, five cases ovulated and 3cases became pregnant, in 2 cases with first grade amenorrhea all conceived, in 4 §cases with second ,grade amenorrhea 2cases ovulated.
The optimum dose of Sexovid was found to be 200-400mg daily for 7-10 days each month. The complication of therapy, was amenorrhea continuing for 2-3 months after administration un 5cases o anovu atorymenses.
In addition to 18 patients , with ovulatory infertility, were evaluated. Seven pregnancies occurred.
The administration of Sexovid (100mg daily for 5-6days each month) appears to be useful therapeutic approach to the problem of ,patients with ovulatory infertility.
키워드
KMID :
0358419700130020003
DOI :
원문 및 링크아웃 정보
등재저널 정보